Borderline Ovarian Tumors Clinical Trial
Official title:
OPTIBOT: Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor (BOT)
Retrospective and prospective multi-center study
Indication: Fertility-sparing surgery for patients with borderline ovarian tumor and
fertility
Objectives:
- Description of the characteristics of the patients of less than 45 years having a
fertility-sparing surgery for borderline ovarian tumors, the modalities of care and
their fertility.
- Validation of a nomogram as an information medium to the patients concerned on their
chance of alive birth according to their personal characteristics
Origin and nature of the specific data:
- Extraction from the database " Tumeurs Malignes Rares de l'Ovaire " (TMRO)
- Collection of retrospective further informations in the participating centers
- Data collection from the patients (questionnaires) The data will be identified by the
TMRO number allocated to every participant of the TMRO study .
Data traffic :
TMRO database extraction for the patients with BOT and corresponding to the inclusion
criteria, supplied by Arcagy-Gineco.
The database will be managed by the coordination team in an anonymous way by means of the
patient identifiers of the TMRO base.
Enrichment of the base by the anonymous questionnaires filled by the patients and the
complementary data transmissions of the centers on anonymised files.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03779399 -
Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor
|